Fingolimod and sphingosine-1-phosphate—modifiers of lymphocyte migration
S Massberg, UH von Andrian - New England Journal of Medicine, 2006 - Mass Medical Soc
New England Journal of Medicine, 2006•Mass Medical Soc
Fingolimod and Sphingosine-1-Phosphate — Modifiers of Lymphocyte Migration | NEJM Skip
to main content NEJM Group Follow Us Facebook Twitter Instagram YouTube LinkedIn Prepare
to become a physician, build your knowledge, lead a health care organization, and advance
your career with NEJM Group information and services. NEJM Evidence NEW! A digital journal
for innovative original research and fresh, bold ideas in clinical trial design and clinical
decision-making. NEJM Catalyst NEW! Peer-reviewed journal featuring in-depth articles to …
to main content NEJM Group Follow Us Facebook Twitter Instagram YouTube LinkedIn Prepare
to become a physician, build your knowledge, lead a health care organization, and advance
your career with NEJM Group information and services. NEJM Evidence NEW! A digital journal
for innovative original research and fresh, bold ideas in clinical trial design and clinical
decision-making. NEJM Catalyst NEW! Peer-reviewed journal featuring in-depth articles to …
Fingolimod was found to exert considerable therapeutic effects in patients with relapsing multiple sclerosis. Drs. Steffen Massberg and Ulrich von Andrian describe how this immunosuppressant works.
The New England Journal Of Medicine